Ceapro Inc. (CVE:CZO – Get Free Report) was down 11.8% on Tuesday . The company traded as low as C$0.23 and last traded at C$0.23. Approximately 5,850 shares changed hands during trading, a decline of 88% from the average daily volume of 50,562 shares. The stock had previously closed at C$0.26.
Ceapro Price Performance
The stock has a 50 day simple moving average of C$0.22 and a two-hundred day simple moving average of C$0.23. The company has a market cap of C$688,880.00, a price-to-earnings ratio of -2.83 and a beta of 1.38. The company has a debt-to-equity ratio of 8.07, a current ratio of 8.54 and a quick ratio of 18.88.
About Ceapro
Ceapro Inc, a biotechnology company, engages in the development and marketing of health and wellness products and technology relating to plant extracts in the United States, Germany, China, Canada, and internationally. The company is involved in the development of proprietary extraction technologies and the application of these technologies to the production, development, and commercialization of active ingredients, such as oat beta glucan and avenanthramides, which are derived from oats and other renewable plant resources for healthcare and cosmetic industries.
Read More
- Five stocks we like better than Ceapro
- Navy Catalyst Ignites Odysight’s Growth Engine
- AST SpaceMobile Plummets on Galactic Q1 Miss: Can Vertical Integration Save the SpaceX Rival?
- Axon Surged After Earnings and Is Still Down Over 50% From Highs
- The Event That Could Redefine Apple’s Summer Rally
Receive News & Ratings for Ceapro Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ceapro and related companies with MarketBeat.com's FREE daily email newsletter.
